洛沙平吸入粉（阿地苏韦）：一种用于治疗激越的新型创新抗精神病药物制剂。
Loxapine inhalation powder (adasuve): a new and innovative formulation of an antipsychotic treatment for agitation.
作者信息
Valdes Jose, Shipley Travis, Rey Jose A
出版信息
P T. 2014 Sep;39(9):621-3, 648.
Abstract
Loxapine inhalation powder (Adasuve): an innovative formulation of an antipsychotic treatment for agitation.
摘要
洛沙平吸入粉（阿达斯韦）：一种用于治疗激越的抗精神病药物创新制剂。
相似文献
1
2
Loxapine inhalation powder: a review of its use in the acute treatment of agitation in patients with bipolar disorder or schizophrenia.洛沙平吸入粉：在双相情感障碍或精神分裂症患者急性治疗激越中的应用评价。
CNS Drugs. 2013 Jun;27(6):479-89. doi: 10.1007/s40263-013-0075-9.
3
Inhaled loxapine (Adasuve) for acute agitation.吸入用洛沙平（阿地苏韦）用于急性激越。
Med Lett Drugs Ther. 2014 Apr 14;56(1440):31-2.
4
The effect of the medicine administration route on health-related quality of life: Results from a time trade-off survey in patients with bipolar disorder or schizophrenia in 2 Nordic countries.药物给药途径对健康相关生活质量的影响：来自北欧2个国家双相情感障碍或精神分裂症患者时间权衡调查的结果。
BMC Psychiatry. 2016 Jul 16;16:244. doi: 10.1186/s12888-016-0930-6.
5
Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.雾化抗精神病药缓解激越：吸入洛沙平治疗与精神分裂症或双相情感障碍相关的激越。
Int J Clin Pract. 2011 Mar;65(3):330-40. doi: 10.1111/j.1742-1241.2010.02615.x. Epub 2010 Dec 29.
6
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.吸入性洛沙平在精神疾病患者急性激越治疗中的作用：一项临床综述
Int J Mol Sci. 2017 Feb 8;18(2):349. doi: 10.3390/ijms18020349.
7
Inhaled loxapine for the urgent treatment of acute agitation associated with schizophrenia or bipolar disorder.吸入用洛沙平用于紧急治疗与精神分裂症或双相情感障碍相关的急性激越。
Curr Med Res Opin. 2016 Jul;32(7):1253-60. doi: 10.1185/03007995.2016.1170004. Epub 2016 Jun 1.
8
Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens.接受慢性稳定抗精神病药物治疗方案的受试者吸入洛沙平的多剂量药代动力学
J Clin Pharmacol. 2015 Sep;55(9):985-94. doi: 10.1002/jcph.502. Epub 2015 May 6.
9
Effect of smoking on the pharmacokinetics of inhaled loxapine.吸烟对吸入性洛沙平药代动力学的影响。
Ther Drug Monit. 2014 Oct;36(5):618-23. doi: 10.1097/FTD.0000000000000048.
10
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.洛沙平吸入剂治疗精神分裂症患者激越的疗效和安全性：一项随机、双盲、安慰剂对照试验。
J Clin Psychiatry. 2011 Oct;72(10):1313-21. doi: 10.4088/JCP.10m06011yel.
引用本文的文献
1
Novel approach for real-time monitoring of carrier-based DPIs delivery process pulmonary route based on modular modified Sympatec HELOS.基于模块化改进的Sympatec HELOS对基于载体的干粉吸入器经肺途径给药过程进行实时监测的新方法。
Acta Pharm Sin B. 2020 Jul;10(7):1331-1346. doi: 10.1016/j.apsb.2020.02.013. Epub 2020 Mar 4.
2
Emerging trends in inhaled drug delivery.吸入式药物传递的新趋势。
Adv Drug Deliv Rev. 2020;157:63-70. doi: 10.1016/j.addr.2020.07.006. Epub 2020 Jul 12.
3
Clinical Outcomes in Patients Taking Inhaled Loxapine, Haloperidol, or Ziprasidone in the Emergency Department.急诊科中吸入洛沙平、氟哌啶醇或齐拉西酮患者的临床结局
Clin Neuropharmacol. 2019 Mar/Apr;42(2):23-26. doi: 10.1097/WNF.0000000000000325.
4
The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.吸入性洛沙平在精神疾病患者急性激越治疗中的作用：一项临床综述
Int J Mol Sci. 2017 Feb 8;18(2):349. doi: 10.3390/ijms18020349.
5
State of Acute Agitation at Psychiatric Emergencies in Europe: The STAGE Study.欧洲精神科急诊中的急性激越状态：STAGE研究
Clin Pract Epidemiol Ment Health. 2016 Oct 27;12:75-86. doi: 10.2174/1745017901612010075. eCollection 2016.
本文引用的文献
1
Is bipolar disorder specifically associated with aggression?双相情感障碍是否与攻击行为有特定关联？
Bipolar Disord. 2012 May;14(3):283-90. doi: 10.1111/j.1399-5618.2012.01006.x.
2
Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.双相 I 障碍患者激越的快速急性治疗：一项多中心、随机、安慰剂对照临床试验，采用吸入洛沙平。
Bipolar Disord. 2012 Feb;14(1):31-40. doi: 10.1111/j.1399-5618.2011.00975.x.
3
Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.洛沙平吸入剂治疗精神分裂症患者激越的疗效和安全性：一项随机、双盲、安慰剂对照试验。
J Clin Psychiatry. 2011 Oct;72(10):1313-21. doi: 10.4088/JCP.10m06011yel.
4
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.精神分裂症个体激越的快速急性治疗：吸入洛沙平的多中心、随机、安慰剂对照研究。
Br J Psychiatry. 2011 Jan;198(1):51-8. doi: 10.1192/bjp.bp.110.081513.
5
Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.全国共病调查复制研究中双相谱系障碍的终生患病率和12个月患病率。
Arch Gen Psychiatry. 2007 May;64(5):543-52. doi: 10.1001/archpsyc.64.5.543.
6
The expert consensus guideline series. Treatment of behavioral emergencies 2005.专家共识指南系列。2005年行为紧急情况的治疗
J Psychiatr Pract. 2005 Nov;11 Suppl 1:5-108; quiz 110-2. doi: 10.1097/00131746-200511001-00002.
7
Prevalence and precipitants of aggression in psychiatric inpatient units.精神科住院病房攻击行为的患病率及诱发因素
Aust N Z J Psychiatry. 2000 Dec;34(6):967-74. doi: 10.1080/000486700271.
8
Effects of diagnosis and context on dangerousness.诊断与背景对危险性的影响。
Am J Psychiatry. 1988 Jun;145(6):728-32. doi: 10.1176/ajp.145.6.728.
Zotero 插件